SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule
ARQL 20.000.0%Jan 16 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (192)3/31/1998 12:48:00 PM
From: scaram(o)uche  Read Replies (2) of 399
 
John:

This deal is actually ("Immunex will elect") structured a bit differently. It had to be, given AHP. However, that's a plus.... this is a biotech-biotech deal that has tangential big bucks behind it. Moreover, this is a deal that allows for multiple products from a single program of a multiple-program company (IMNX). This is a great match.

Agree completely with your sentiment. Now, Gordon, let's see that IND that's supposed to break up the boredom.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News